ANTIMICROBIAL OPTIMIZATION AFTER POSITIVE PNEUMOCOCCAL URINARY ANTIGEN TESTING IN HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA: A RETROSPECTIVE COHORT STUDY
Mediterranean Journal of Hematology and Infectious Diseases · 2026-10-31 · 18 (1) · e2026081
DOI: 10.4084/mjhid.2026.081 ↗Abstract
Background: Pneumococcal urinary antigen testing (PUAT) rapidly supports pneumococcal etiology in community-acquired pneumonia (CAP), but its impact on antimicrobial optimization in routine care remains uncertain. Objectives: To evaluate antimicrobial spectrum narrowing after positive PUAT in hospitalized adults with CAP and to describe other antimicrobial optimization actions. Methods: We conducted a retrospective observational cohort study at a Portuguese tertiary hospital including adults hospitalized with CAP and positive PUAT between January 2020 and December 2024. The primary endpoint was antimicrobial spectrum narrowing. Absence or early discontinuation of atypical coverage and intravenous-to-oral switch were analyzed separately. Results: Among 332 episodes, antimicrobial spectrum narrowing occurred in 30 (9.0%), after a median of 3 days (Q1-Q3, 2-4). De-escalation to ampicillin or amoxicillin occurred in 7 episodes (2.1%). Narrowing was less frequent among patients initially treated with amoxicillin/clavulanate (10.0% vs 43.7%; p
EUVIMED